Founded hauv 2009, JYMed yog ib lub tuam txhab tshuaj hauv Suav teb uas koom nrog R & D, kev tsim khoom, kev lag luam, thiab kev tsim kho thiab kev tsim cov khoom peptide. Lub tuam txhab muaj kwv yees li 570 tus neeg ua haujlwm, nrog rau pawg tswj hwm tseem ceeb tsim los ntawm cov kws tshaj lij nrog cov kws tshaj lij thiab tshaj 20 xyoo ntawm kev paub hauv kev lag luam peptide. JYMed ua haujlwm rau ib lub chaw tshawb fawb thiab ob lub chaw tsim khoom loj, ua tiav ntau-tuj nplai ntau lawm hauv peptides, tso nws ua tus thawj coj hauv kev lag luam.
Taw qhia ntawm JYMed, US FDA tshuaj xyuas peptide chaw tsim tshuaj paus. Cov khoom tshwj xeeb: cosemtic peptide, peptide APIs, kev cai peptides, xws li, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, thiab lwm yam. Yog xav paub ntxiv, thov hu rau
Email: jymed@jymedtech.com